Sigyn Therapeutics, Inc. (SIGY) SEC Filings https://www.sigyntherapeutics.com/investors/sec-filings/quarterly-reports/rss Sigyn Therapeutics, Inc. (SIGY) - Quarterly Reports en-us https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png Sigyn Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-25-023387/0001493152-25-023387.pdf Fri, 14 Nov 25 16:05:00 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-25-023387/0001493152-25-023387.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-026704/0001641172-25-026704.pdf Fri, 05 Sep 25 15:49:17 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-026704/0001641172-25-026704.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024221/0001641172-25-024221.pdf Fri, 15 Aug 25 06:06:31 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024221/0001641172-25-024221.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-011815/0001641172-25-011815.pdf Tue, 20 May 25 17:31:35 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-011815/0001641172-25-011815.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-010720/0001641172-25-010720.pdf Thu, 15 May 25 14:16:50 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-010720/0001641172-25-010720.pdf <![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-046847/0001493152-24-046847.pdf Tue, 19 Nov 24 16:58:20 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-046847/0001493152-24-046847.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-046127/0001493152-24-046127.pdf Fri, 15 Nov 24 06:03:21 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-046127/0001493152-24-046127.pdf <![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-033048/0001493152-24-033048.pdf Mon, 19 Aug 24 14:49:20 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-033048/0001493152-24-033048.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-032398/0001493152-24-032398.pdf Wed, 14 Aug 24 17:14:16 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-032398/0001493152-24-032398.pdf <![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-019221/0001493152-24-019221.pdf Tue, 14 May 24 16:07:39 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-24-019221/0001493152-24-019221.pdf